Prevention of Early Sudden Cardiac Death after Myocardial Infarction Using the Wearable Cardioverter Defibrillator—Results from a Real-World Cohort

Background: After acute myocardial infarction (AMI), patients are at risk of sudden cardiac death. The VEST trial failed to show a reduction in arrhythmic mortality in AMI patients with an LVEF ≤ 35% prescribed with a WCD, having a lower-than-expected WCD wearing compliance. Objectives: The aim was...

Descripción completa

Detalles Bibliográficos
Autores principales: Rohrer, Ursula, Manninger, Martin, Fiedler, Lukas, Steinwender, Clemens, Binder, Ronald K., Stühlinger, Markus, Zirngast, Birgit, Zweiker, David, Zirlik, Andreas, Scherr, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419414/
https://www.ncbi.nlm.nih.gov/pubmed/37568431
http://dx.doi.org/10.3390/jcm12155029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419414/
https://www.ncbi.nlm.nih.gov/pubmed/37568431
http://dx.doi.org/10.3390/jcm12155029

Ejemplares similares